The probe exhibited markedly higher affinity for cancer cell lines (HepG2, MCF-7, A549) than for normal liver cells (L02), confirming the potential of Gal as a broad, tumor-targeting ligand for imaging and therapy. The gene discussed is GAL; the disease is neoplasm.